Hepatitis E Virus Prevalence and Associated Risk Factors in High-Risk Groups: A Cross-Sectional Study

Yıl: 2022 Cilt: 33 Sayı: 7 Sayfa Aralığı: 615 - 624 Metin Dili: İngilizce DOI: 10.5152/tjg.2022.21493 İndeks Tarihi: 16-08-2022

Hepatitis E Virus Prevalence and Associated Risk Factors in High-Risk Groups: A Cross-Sectional Study

Öz:
Background: Seroepidemiology, risk factors to hepatitis E virus exposure, and prevalence of hepatitis E virus viremia have not yet been investigated among patients under immunosuppression or with liver disease that are high risk for infection in Turkey. Methods: In this cross-sectional study, 292 consecutive serum samples from renal transplant recipients, allogeneic hematopoietic stem cell transplant recipients, patients with acute hepatitis, and patients with chronic hepatitis C were prospectively collected in a ter tiary university hospital. Sera were tested for hepatitis E virus immunoglobulin G/immunoglobulin M and hepatitis E virus ribonucleic acid using commercial enzyme-linked immunosorbent assay and in-house nested polymerase chain reaction with Sanger sequencing, respectively. Sociodemographic, clinical, laboratory data, and risk factors were collected using a questionnaire and hospital database. Multiple logistic regression analysis was employed to identify independent predictors for anti-hepatitis E virus seropositivity. Results: Among all patients, only 2 patients (1 renal transplant recipient and 1 patient with acute hepatitis) were identified as having hepatitis E virus genotype 3 viremia. Hepatitis E virus viremia rate was 0.6% in whole group. These patients showed no signs of chronic hepatitis E virus infection for 6 months and were spontaneously seroconverted 6 months after enrollment. Anti-hepatitis E virus IgG was positive in 29 patients yielding a hepatitis E virus seroprevalence of 9.9%. Older age (adjusted odds ratio: 1.03, 95% CI, 1.00-1.06; P = .022) and eating undercooked meat (adjusted odds ratio: 3.11, 95% CI, 1.08-8.92; P = .034) were independent risk factors to anti hepatitis E virus seropositivity in all patients. Similarly, multiple logistic regression analysis demonstrated that age (adjusted odds ratio: 1.03, 95% CI, 0.99-1.07, P = .058) and eating undercooked meat (adjusted odds ratio: 5.77, 95% CI, 1.49-22.25, P = .011) were indepen dent risk factors for anti-hepatitis E virus IgG positivity in the liver disease subgroup consisting of acute hepatitis and chronic hepatitis C patients. Conclusion: The hepatitis E virus seroprevalence rate was high (9.9%), despite low viremia rate (0.6%) in high-risk patients. The emer gence of hepatitis E virus genotype 3 might indicate a serious problem for these patients. Future investigations are needed to elucidate foodborne transmission routes of hepatitis E virus in Turkey.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Reyes GR, Purdy MA, Kim JP, et al. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science. 1990;247(4948):1335-1339. [CrossRef]
  • 2. Tam AW, Smith MM, Guerra ME, et al. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology. 1991;185(1):120-131. [CrossRef]
  • 3. Hoofnagle JH, Nelson KE, Purcell RH. Hepatitis E. N Engl J Med. 2012;367(13):1237-1244. [CrossRef]
  • 4. Lee GH, Tan BH, Teo EC, et al. Chronic infection with camelid hepatitis E virus in a liver transplant recipient who regularly con sumes camel meat and milk. Gastroenterology. 2016;150(2):355-7. e3. [CrossRef]
  • 5. Aslan AT, Balaban HY. Hepatitis E virus: epidemiology, diagnosis, clinical manifestations, and treatment. World J Gastroenterol. 2020;26(37):5543-5560. [CrossRef]
  • 6. Kamar N, Selves J, Mansuy JM, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med. 2008;358(8):811-817. [CrossRef]
  • 7. Hartl J, Otto B, Madden RG, et al. Hepatitis E seroprevalence in Europe: a meta-analysis. Viruses. 2016;8(8):211. [CrossRef]
  • 8. Pas SD, Streefkerk RH, Pronk M, et al. Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompro mised and immunocompetent patients. J Clin Virol. 2013;58(4):629- 634. [CrossRef]
  • 9. Aspinall EJ, Couturier E, Faber M, et al. Hepatitis E virus infection in Europe: surveillance and descriptive epidemiology of confirmed cases, 2005-2015. Euro Surveill. 2017;22(26). [CrossRef]
  • 10. Mizuo H, Suzuki K, Takikawa Y, et al. Polyphyletic strains of hepa titis E virus are responsible for sporadic cases of acute hepatitis in Japan. J Clin Microbiol. 2002;40(9):3209-3218. [CrossRef]
  • 11. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol. 1990;215(3):403-410. [CrossRef]
  • 12. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994;22(22):4673-4680. [CrossRef]
  • 13. Kumar S, Stecher G, Li M, Knyaz C, Tamura K. MEGA X: molecular evolutionary genetics analysis across computing platforms. Mol Biol Evol. 2018;35(6):1547-1549. [CrossRef]
  • 14. Wong RJ, Cheung R, Gish RG, Chitnis AS. Prevalence of hepati tis E infection among adults with concurrent chronic liver disease. J Viral Hepat. 2021;28(11):1643-1655. [CrossRef]
  • 15. Grigas J, Montoya M, Simkute E, et al. Molecular characterization and seroprevalence of hepatitis E virus in inflammatory bowel disease patients and solid organ transplant recipients. Viruses. 2021;13(4). [CrossRef]
  • 16. Mansuy JM, Bendall R, Legrand-Abravanel F, et al. Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis. 2011;17(12):2309-2312. [CrossRef]
  • 17. Leblebicioglu H, Ozaras R. Hepatitis E virus infection in Turkey: a systematic review. Ann Clin Microbiol Antimicrob. 2018;17(1):17. [CrossRef]
  • 18. Sadik S, van Rijckevorsel GGC, van Rooijen MS, Sonder GJB, Bruisten SM. Seroprevalence of hepatitis E virus differs in Dutch and first generation migrant populations in Amsterdam, the Netherlands: a cross-sectional study. BMC Infect Dis. 2016;16(1):659. [CrossRef]
  • 19. Yaşar O, Karatayli E, Cengiz G, et al. HEV seroprevalence in blood donors in Turkey by two commercial total anti-HEV Ab ELISA kits. J Med Virol. 2019;91(12):2174-2181. [CrossRef]
  • 20. Buescher G, Ozga AK, Lorenz E, et al. Hepatitis E seroprevalence and viremia rate in immunocompromised patients: a systematic review and meta-analysis. Liver Int. 2021;41(3):449-455. [CrossRef]
  • 21. Versluis J, Pas SD, Agteresch HJ, et al. Hepatitis E virus: an under estimated opportunistic pathogen in recipients of allogeneic hemat opoietic stem cell transplantation. Blood. 2013;122(6):1079-1086. [CrossRef]
  • 22. Ankcorn MJ, Fox TA, Ijaz S, et al. Characterising the risk of hepa titis E virus infection in haematological malignancies: a UK prospec tive prevalence study. Br J Haematol. 2019;186(1):191-195. [CrossRef]
  • 23. Ankcorn MJ, Ijaz S, Poh J, et al. Toward systematic screening for persistent hepatitis E virus infections in transplant patients. Trans plantation. 2018;102(7):1139-1147. [CrossRef]
  • 24. Hewitt PE, Ijaz S, Brailsford SR, et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet. 2014;384(9956):1766-1773. [CrossRef]
  • 25. Roth NJ, Schäfer W, Alexander R, et al. Low hepatitis E virus RNA prevalence in a large scale survey of United States source plasma donors. Transfusion. 2017;57(12):2958-2964. [CrossRef]
  • 26. Harritshøj LH, Hother CE, Sengeløv H, et al. Epidemiology of hepatitis E virus infection in a cohort of 4023 immunocompromised patients. Int J Infect Dis. 2020;91:188-195. [CrossRef].
  • 27. Van der Poel WH. Food and environmental routes of hepatitis E virus transmission. Curr Opin Virol. 2014;4:91-96. [CrossRef]
  • 28. Kamar N, Garrouste C, Haagsma EB, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology. 2011;140(5):1481-1489. [CrossRef]
  • 29. Holm DK, Moessner BK, Engle RE, et al. Declining prevalence of hepatitis E antibodies among Danish blood donors. Transfusion. 2015;55(7):1662-1667. [CrossRef]
APA balaban h, Aslan A, Akdoğan Kittana F, ALP A, Dag O, Ayar Ş, vahabov j, Simsek C, YILDIRIM T, GOKKER H, ERGUNAY K, ERDEM Y, Buyukasik Y, simsek h (2022). Hepatitis E Virus Prevalence and Associated Risk Factors in High-Risk Groups: A Cross-Sectional Study. , 615 - 624. 10.5152/tjg.2022.21493
Chicago balaban hatice yasemin,Aslan Abdullah Tarık,Akdoğan Kittana Fatma Nur,ALP ALPASLAN,Dag Osman,Ayar Şefika Nur,vahabov javanshir,Simsek Cem,YILDIRIM Tolga,GOKKER HAKAN,ERGUNAY KORAY,ERDEM YUNUS,Buyukasik Yahya,simsek halis Hepatitis E Virus Prevalence and Associated Risk Factors in High-Risk Groups: A Cross-Sectional Study. (2022): 615 - 624. 10.5152/tjg.2022.21493
MLA balaban hatice yasemin,Aslan Abdullah Tarık,Akdoğan Kittana Fatma Nur,ALP ALPASLAN,Dag Osman,Ayar Şefika Nur,vahabov javanshir,Simsek Cem,YILDIRIM Tolga,GOKKER HAKAN,ERGUNAY KORAY,ERDEM YUNUS,Buyukasik Yahya,simsek halis Hepatitis E Virus Prevalence and Associated Risk Factors in High-Risk Groups: A Cross-Sectional Study. , 2022, ss.615 - 624. 10.5152/tjg.2022.21493
AMA balaban h,Aslan A,Akdoğan Kittana F,ALP A,Dag O,Ayar Ş,vahabov j,Simsek C,YILDIRIM T,GOKKER H,ERGUNAY K,ERDEM Y,Buyukasik Y,simsek h Hepatitis E Virus Prevalence and Associated Risk Factors in High-Risk Groups: A Cross-Sectional Study. . 2022; 615 - 624. 10.5152/tjg.2022.21493
Vancouver balaban h,Aslan A,Akdoğan Kittana F,ALP A,Dag O,Ayar Ş,vahabov j,Simsek C,YILDIRIM T,GOKKER H,ERGUNAY K,ERDEM Y,Buyukasik Y,simsek h Hepatitis E Virus Prevalence and Associated Risk Factors in High-Risk Groups: A Cross-Sectional Study. . 2022; 615 - 624. 10.5152/tjg.2022.21493
IEEE balaban h,Aslan A,Akdoğan Kittana F,ALP A,Dag O,Ayar Ş,vahabov j,Simsek C,YILDIRIM T,GOKKER H,ERGUNAY K,ERDEM Y,Buyukasik Y,simsek h "Hepatitis E Virus Prevalence and Associated Risk Factors in High-Risk Groups: A Cross-Sectional Study." , ss.615 - 624, 2022. 10.5152/tjg.2022.21493
ISNAD balaban, hatice yasemin vd. "Hepatitis E Virus Prevalence and Associated Risk Factors in High-Risk Groups: A Cross-Sectional Study". (2022), 615-624. https://doi.org/10.5152/tjg.2022.21493
APA balaban h, Aslan A, Akdoğan Kittana F, ALP A, Dag O, Ayar Ş, vahabov j, Simsek C, YILDIRIM T, GOKKER H, ERGUNAY K, ERDEM Y, Buyukasik Y, simsek h (2022). Hepatitis E Virus Prevalence and Associated Risk Factors in High-Risk Groups: A Cross-Sectional Study. Turkish Journal of Gastroenterology, 33(7), 615 - 624. 10.5152/tjg.2022.21493
Chicago balaban hatice yasemin,Aslan Abdullah Tarık,Akdoğan Kittana Fatma Nur,ALP ALPASLAN,Dag Osman,Ayar Şefika Nur,vahabov javanshir,Simsek Cem,YILDIRIM Tolga,GOKKER HAKAN,ERGUNAY KORAY,ERDEM YUNUS,Buyukasik Yahya,simsek halis Hepatitis E Virus Prevalence and Associated Risk Factors in High-Risk Groups: A Cross-Sectional Study. Turkish Journal of Gastroenterology 33, no.7 (2022): 615 - 624. 10.5152/tjg.2022.21493
MLA balaban hatice yasemin,Aslan Abdullah Tarık,Akdoğan Kittana Fatma Nur,ALP ALPASLAN,Dag Osman,Ayar Şefika Nur,vahabov javanshir,Simsek Cem,YILDIRIM Tolga,GOKKER HAKAN,ERGUNAY KORAY,ERDEM YUNUS,Buyukasik Yahya,simsek halis Hepatitis E Virus Prevalence and Associated Risk Factors in High-Risk Groups: A Cross-Sectional Study. Turkish Journal of Gastroenterology, vol.33, no.7, 2022, ss.615 - 624. 10.5152/tjg.2022.21493
AMA balaban h,Aslan A,Akdoğan Kittana F,ALP A,Dag O,Ayar Ş,vahabov j,Simsek C,YILDIRIM T,GOKKER H,ERGUNAY K,ERDEM Y,Buyukasik Y,simsek h Hepatitis E Virus Prevalence and Associated Risk Factors in High-Risk Groups: A Cross-Sectional Study. Turkish Journal of Gastroenterology. 2022; 33(7): 615 - 624. 10.5152/tjg.2022.21493
Vancouver balaban h,Aslan A,Akdoğan Kittana F,ALP A,Dag O,Ayar Ş,vahabov j,Simsek C,YILDIRIM T,GOKKER H,ERGUNAY K,ERDEM Y,Buyukasik Y,simsek h Hepatitis E Virus Prevalence and Associated Risk Factors in High-Risk Groups: A Cross-Sectional Study. Turkish Journal of Gastroenterology. 2022; 33(7): 615 - 624. 10.5152/tjg.2022.21493
IEEE balaban h,Aslan A,Akdoğan Kittana F,ALP A,Dag O,Ayar Ş,vahabov j,Simsek C,YILDIRIM T,GOKKER H,ERGUNAY K,ERDEM Y,Buyukasik Y,simsek h "Hepatitis E Virus Prevalence and Associated Risk Factors in High-Risk Groups: A Cross-Sectional Study." Turkish Journal of Gastroenterology, 33, ss.615 - 624, 2022. 10.5152/tjg.2022.21493
ISNAD balaban, hatice yasemin vd. "Hepatitis E Virus Prevalence and Associated Risk Factors in High-Risk Groups: A Cross-Sectional Study". Turkish Journal of Gastroenterology 33/7 (2022), 615-624. https://doi.org/10.5152/tjg.2022.21493